✦ LIBER ✦

Chimeric antigen receptor T cells for ALL

✍ Scribed by Amrolia, Persis J; Pule, Martin

Book ID: 126614900
Publisher: The Lancet
Year: 2015
Tongue: English
Weight: 159 KB
Volume: 385
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(14)61729-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chimeric Antigen Receptor–Modified T Cel

Chimeric Antigen Receptor–Modified T Cells in CLL

📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 323 KB

Chimeric Antigen Receptor–Modified T Cel

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

✍ Grupp, Stephan A.; Kalos, Michael; Barrett, David; Aplenc, Richard; Porter, Davi 📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 850 KB

Innovation and opportunity for chimeric

Innovation and opportunity for chimeric antigen receptor targeted T cells

✍ Melenhorst, J. Joseph; Levine, Bruce L. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 138 KB

Chimeric Antigen Receptor T Cells for Su

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

✍ Maude, Shannon L.; Frey, Noelle; Shaw, Pamela A.; Aplenc, Richard; Barrett, Davi 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 661 KB

Chimeric Antigen Receptor T Cells for Su

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

✍ Maude, Shannon L.; Frey, Noelle; Shaw, Pamela A.; Aplenc, Richard; Barrett, Davi 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 661 KB

## Background: Relapsed acute lymphoblastic leukemia (all) is difficult to treat despite the availability of aggressive therapies. chimeric antigen receptor-modified t cells targeting cd19 may overcome many limitations of conventional therapies and induce remission in patients with refractory disea

Chimeric antigen receptor modified T cel

Chimeric antigen receptor modified T cell therapy for B cell malignancies

✍ Turtle, Cameron J. 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 312 KB